Equivalent Brains Studios IPO Itemizing: ₹54 share listed at ₹95, then broke to decrease circuit – #INA

Equivalent Brains Studios IPO Itemizing: Rip-off 1992: Shares of Equivalent Brains Studios, which offered VFX companies in The Harshad Mehta Story and Rocket Boys, had a superb entry on NSE SME at present. Nonetheless, attributable to revenue reserving it got here down once more. Its IPO acquired general bids of greater than 544 instances. Shares have been issued beneath the IPO at a value of Rs 54. Right now it entered NSE SME at Rs 95.00, which suggests IPO traders received an inventory acquire of 75.93 % (Equivalent Brains Studios Itemizing Achieve). Nonetheless, the enjoyment of IPO traders quickly pale because the shares crashed. It fell to the decrease circuit of Rs 90.25 (Equivalent Brains Studios Share Worth), which suggests IPO traders are actually making 67.13 % revenue.

Equivalent Brains Studios IPO received a powerful response

Equivalent Brains Studios’ ₹19.95 crore IPO was open for subscription from December 18-20. This IPO acquired an amazing response from traders and general it was subscribed 544.28 instances. On this, the portion reserved for Certified Institutional Consumers (QIB) was stuffed 187.36 instances, the portion for Non-Institutional Buyers (NII) was 1,020.2 instances and the portion for retail traders was stuffed 544.28 instances.

Underneath this IPO, 36.94 lakh new shares with face worth of Rs 10 have been issued. The cash raised by these shares can be utilized by the corporate for renovation of the prevailing workplace and studio in Andheri, organising of colour grading digital intermediate and sound studio within the new department workplace in Andheri, opening of a brand new department workplace in Lucknow, buy of computer systems and storage programs and software program, To fulfill the elevated necessities of working capital and for common company functions.

About Equivalent Brains Studios

Within the 12 months 2019, Equivalent Brains Studios gives VFX companies to movies, internet collection, TV collection, documentaries and commercials. Speaking in regards to the monetary well being of the corporate, it has constantly strengthened. Within the monetary 12 months 2022, it had a web revenue of Rs 51.01 lakh, which jumped to Rs 1.61 crore within the subsequent monetary 12 months 2023 and to Rs 5.35 crore within the monetary 12 months 2024. Throughout this era, the corporate’s income elevated at a compound development price (CAGR) of greater than 127 % yearly to Rs 20.26 crore. Speaking in regards to the present monetary 12 months 2024-25, within the first half April-September 2024, it has achieved a web revenue of Rs 2.41 crore and a income of Rs 11.50 crore.

Senores Pharma IPO Allotment: Stepwise option to examine allotment, there’s scope for a lot revenue on itemizing